Dr. Haupert: Vitrectomized Eyes


OUR COLLEAGUE: Christopher L. Haupert, MD — West Des Moines, IA

"Anti-VEGF injections every 6 to 8 weeks to maintain vision was a hefty burden for my patient. Post-ILUVIEN, she has not needed any additional therapy."
— Christopher L. Haupert, MD

Above results are from a single case; results may vary.


Dr. Haupert is a vitreoretinal specialist licensed in the state of Iowa who practices at Iowa Retina Consultants.

Academic affiliations:
  • Medical School – University of Iowa, Carver College of Medicine, Iowa City, Iowa
  • Residency – Chief Resident at Emory University, Atlanta, Georgia
  • Fellowship – Vitreoretinal Surgical, Duke University, Durham, North Carolina


Patient Profile 1
Sex: Female
Age: 74
Treated Eye: OD
Lens Status: Pseudophakic
Comorbidities:
  • None
Duration of Disease:
    DM: 29 years
    DME: 12 years
Treatment history:
14X Anti-VEGF
3X corticosteroid
1X Focal grid laser
Vitrectomy

Reasons Dr. Haupert chose ILUVIEN:
  • Anti-VEGF injections were needed every 6 to 8 weeks to maintain vision
  • Patient considered the frequency of treatment to be burdensome
  • Prior response to corticosteroid therapy with no clinically significant increase in IOP


Retinal Thickness (µm)
Retinal Thickness
Best Corrected Visual Acuity (BCVA)
Best Corrected Visual Acuity
IOP: Intraocular Pressure
Intraocular Pressure


Patient Results
ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg:

Patient Outcome
  • ILUVIEN with CONTINUOUS MICRODOSING™ Delivery was initiated to provide a long-lasting treatment while decreasing patient treatment burden
  • ILUVIEN treatment reduced retinal edema within 4 months
  • Improvement in visual acuity was seen at 9 months
  • No clinically significant rise in IOP was observed
  • No additional treatment needed for 12 months post ILUVIEN in a vitrectomized eye
Selected OCT Scans
References:
1. Data on File. Alimera Sciences, Inc.



"Prior to ILUVIEN, I aggressively treated this patient’s macular edema to protect her vision. Since ILUVIEN, the patient’s edema has been controlled for over a year without need of any other injections."
— Dr. Haupert